NCT02665208View on ClinicalTrials.gov

A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients

NACompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2017

Conditions
Smoking Cessation
Interventions
OTHER

Treatment As Usual (TAU)

informational pamphlets and information from 1800 quit line + prescription for nicotine replacement therapy (NRT) based on on the quantity of baseline self-reported smoking, or nicotine replacement gum (2mg)

DRUG

Nicotine Replacement Therapies

a prescription for a nicotine replacement therapy (NRT) (i.e. nicotine replacement patches based on the quantity of baseline self-reported smoking, or nicotine replacement gum (2mg)

BEHAVIORAL

Text Message Intervention (TMI)

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT02665208 - A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients | Biotech Hunter | Biotech Hunter